Klotho Neurosciences Inc (KLTO)

$0.55 +0.08 (17.03%)
Market Cap 32.92M
Revenue (ttm) 0.00
Net Income (ttm) -6.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,846,000
Avg Vol 2,266,974
Day's Range N/A - N/A
Shares Out 70.34M
Stochastic %K 77%
Beta 10.03
Analysts Strong Buy
Price Target N/A

Company Profile

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha,...

Industry: Biotechnology
Sector: Healthcare
Phone: 833 931 6330
Address:
13576 Walnut Street, Suite A, Omaha, United States
Beanie_Mojo
Beanie_Mojo Nov. 11 at 3:05 PM
$KLTO needs volume,
0 · Reply
Rod75b15
Rod75b15 Nov. 11 at 2:32 PM
$KLTO https://finance.yahoo.com/news/klotho-neurosciences-wins-2025-biotech-150300137.html?guccounter=1
0 · Reply
Beanie_Mojo
Beanie_Mojo Nov. 10 at 8:43 PM
$KLTO
0 · Reply
Beanie_Mojo
Beanie_Mojo Nov. 10 at 8:41 PM
$KLTO is somethings brewing? ♨️ not a normal days pattern 🤔
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 10 at 4:24 PM
🎯 Target Hit 🏁 📨 From Nov 6, 2025 🪙 $KLTO 💵 Entry: $0.4620 ✅ Exit: $0.5320 💰 P/L: +15.15% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
Beanie_Mojo
Beanie_Mojo Nov. 10 at 1:36 PM
$KLTO up 5% down 10% up 3% down 8% up 7% down 12% ... ravage continues.....
0 · Reply
Joao78
Joao78 Nov. 10 at 9:59 AM
$KLTO Nice. Shorts are out so we willl probably fly!
0 · Reply
LuckKev
LuckKev Nov. 10 at 12:41 AM
$KLTO 10cts soon after dillution , then R/S , repeat the process
0 · Reply
LuckKev
LuckKev Nov. 10 at 12:40 AM
$KLTO Scam marketing
0 · Reply
LuckKev
LuckKev Nov. 10 at 12:40 AM
$KLTO Longevity.🤣🤣🤣😂😂
0 · Reply
Latest News on KLTO
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award

Nov 7, 2025, 10:03 AM EST - 4 days ago

Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award

Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston

Oct 16, 2025, 8:00 AM EDT - 26 days ago

Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston

Klotho Neurosciences Announces Expiration of Letter of Intent

Oct 7, 2025, 6:20 PM EDT - 4 weeks ago

Klotho Neurosciences Announces Expiration of Letter of Intent

Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership

Sep 30, 2025, 8:30 AM EDT - 6 weeks ago

Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership

Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

Sep 8, 2025, 8:00 AM EDT - 2 months ago

Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market

Aug 18, 2025, 8:30 AM EDT - 3 months ago

Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market

Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology

Aug 12, 2025, 6:00 AM EDT - 3 months ago

Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology

UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Jul 25, 2025, 9:05 PM EDT - 3 months ago

UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Jul 24, 2025, 1:30 PM EDT - 3 months ago

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets

Jul 22, 2025, 10:21 AM EDT - 4 months ago

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets

Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules

Jul 16, 2025, 6:00 AM EDT - 4 months ago

Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules

Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")

Jul 10, 2025, 5:00 AM EDT - 4 months ago

Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")

This Penny Stock Exploded 500% In June: What You Need To Know

Jun 30, 2025, 11:07 AM EDT - 4 months ago

This Penny Stock Exploded 500% In June: What You Need To Know

Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS

Jun 30, 2025, 2:00 AM EDT - 4 months ago

Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population

Jun 24, 2025, 5:00 AM EDT - 5 months ago

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population

KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS

Jun 18, 2025, 7:00 AM EDT - 5 months ago

KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS

KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT

Jun 16, 2025, 7:00 AM EDT - 5 months ago

KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT

Klotho Neurosciences: What's Behind The Nine-Fold Rise In KLTO Stock?

Jun 10, 2025, 11:00 AM EDT - 5 months ago

Klotho Neurosciences: What's Behind The Nine-Fold Rise In KLTO Stock?

KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO ("α-KLOTHO")

Jun 9, 2025, 7:00 AM EDT - 5 months ago

KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO ("α-KLOTHO")

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

Jan 8, 2025, 11:00 AM EST - 10 months ago

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

ANEW MEDICAL, INC. Secures Key Patent in Europe for Human Klotho Gene RNA Slice Variant and Protein

Jun 26, 2024, 5:00 AM EDT - 1 year ago

ANEW MEDICAL, INC. Secures Key Patent in Europe for Human Klotho Gene RNA Slice Variant and Protein

Beanie_Mojo
Beanie_Mojo Nov. 11 at 3:05 PM
$KLTO needs volume,
0 · Reply
Rod75b15
Rod75b15 Nov. 11 at 2:32 PM
$KLTO https://finance.yahoo.com/news/klotho-neurosciences-wins-2025-biotech-150300137.html?guccounter=1
0 · Reply
Beanie_Mojo
Beanie_Mojo Nov. 10 at 8:43 PM
$KLTO
0 · Reply
Beanie_Mojo
Beanie_Mojo Nov. 10 at 8:41 PM
$KLTO is somethings brewing? ♨️ not a normal days pattern 🤔
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 10 at 4:24 PM
🎯 Target Hit 🏁 📨 From Nov 6, 2025 🪙 $KLTO 💵 Entry: $0.4620 ✅ Exit: $0.5320 💰 P/L: +15.15% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
Beanie_Mojo
Beanie_Mojo Nov. 10 at 1:36 PM
$KLTO up 5% down 10% up 3% down 8% up 7% down 12% ... ravage continues.....
0 · Reply
Joao78
Joao78 Nov. 10 at 9:59 AM
$KLTO Nice. Shorts are out so we willl probably fly!
0 · Reply
LuckKev
LuckKev Nov. 10 at 12:41 AM
$KLTO 10cts soon after dillution , then R/S , repeat the process
0 · Reply
LuckKev
LuckKev Nov. 10 at 12:40 AM
$KLTO Scam marketing
0 · Reply
LuckKev
LuckKev Nov. 10 at 12:40 AM
$KLTO Longevity.🤣🤣🤣😂😂
0 · Reply
LuckKev
LuckKev Nov. 10 at 12:39 AM
$KLTO They will have to raise cash soon.... They have burnt 12 million last year , i guess they will burn 25 this year at least... They will have to raise cash...
0 · Reply
LuckKev
LuckKev Nov. 9 at 9:28 AM
$KLTO This will crash and finish badly!!!
0 · Reply
LuckKev
LuckKev Nov. 9 at 9:27 AM
$KLTO massively overpriced
0 · Reply
LuckKev
LuckKev Nov. 9 at 9:26 AM
$KLTO Dirty stock , you will puke
0 · Reply
LuckKev
LuckKev Nov. 9 at 9:25 AM
$KLTO I am shorting it , money printing scam...
0 · Reply
LuckKev
LuckKev Nov. 9 at 9:24 AM
$KLTO no real product.. years from selling anything , they need money from shareholders .
0 · Reply
LuckKev
LuckKev Nov. 9 at 9:22 AM
$KLTO 0.15 in 2 weeks ... Dilution is coming for you
0 · Reply
Beanie_Mojo
Beanie_Mojo Nov. 7 at 10:16 PM
$KLTO
0 · Reply
Tycoon_Trader
Tycoon_Trader Nov. 7 at 8:45 PM
$KLTO https://finviz.com/news/223018/klotho-neurosciences-wins-the-2025-biotech-breakthrough-cell-therapy-innovation-of-the-year-award
0 · Reply
Luckystrange
Luckystrange Nov. 7 at 6:14 PM
$KLTO doesn’t seem to matter 
0 · Reply
pvreporter
pvreporter Nov. 7 at 3:15 PM
$KLTO good news! https://finance.yahoo.com/news/klotho-neurosciences-wins-2025-biotech-150300137.html
0 · Reply
Beanie_Mojo
Beanie_Mojo Nov. 6 at 11:03 PM
$KLTO wtf is goin on..? every 1 penny 🔼up 1 nickel 🔽 down. can't even break a $ 1.
0 · Reply